Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥187.71 Million ≈ $27.47 Million USD) by net assets (CN¥3.27 Billion ≈ $478.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Beijing New Oriental Star Petrochemical Engineering Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Beijing New Oriental Star Petrochemical Engineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Beijing New Oriental Star Petrochemical (002755) financial obligations for a breakdown of total debt and financial obligations.
Beijing New Oriental Star Petrochemical Engineering Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing New Oriental Star Petrochemical Engineering Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Kangtai Biological Products Co Ltd
SHE:300601
|
0.042x |
|
Transportadora de Gas del Sur SA B
BA:TGSU2
|
0.045x |
|
Asahi India Glass Limited
NSE:ASAHIINDIA
|
0.038x |
|
DRDGOLD Limited
F:DUBA
|
0.066x |
|
OLAM GROUP LTD
F:K25
|
N/A |
|
Bavarian Nordic
CO:BAVA
|
0.098x |
|
SOC.BIC UNS.ADR1/2/EO382
F:BIF0
|
N/A |
|
Yunnan Shennong Agricultural Industry Group Co Ltd
SHG:605296
|
-0.018x |
Annual Cash Flow Conversion Efficiency for Beijing New Oriental Star Petrochemical Engineering Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Beijing New Oriental Star Petrochemical Engineering Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 002755 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.14 Billion ≈ $459.81 Million |
CN¥411.36 Million ≈ $60.19 Million |
0.131x | +1583.47% |
| 2023-12-31 | CN¥3.01 Billion ≈ $440.56 Million |
CN¥-26.57 Million ≈ $-3.89 Million |
-0.009x | +49.65% |
| 2022-12-31 | CN¥3.01 Billion ≈ $440.95 Million |
CN¥-52.81 Million ≈ $-7.73 Million |
-0.018x | -109.96% |
| 2021-12-31 | CN¥3.23 Billion ≈ $472.29 Million |
CN¥567.71 Million ≈ $83.07 Million |
0.176x | -8.07% |
| 2020-12-31 | CN¥3.03 Billion ≈ $443.85 Million |
CN¥580.38 Million ≈ $84.93 Million |
0.191x | -9.93% |
| 2019-12-31 | CN¥2.52 Billion ≈ $368.25 Million |
CN¥534.62 Million ≈ $78.23 Million |
0.212x | -21.33% |
| 2018-12-31 | CN¥1.84 Billion ≈ $269.39 Million |
CN¥497.16 Million ≈ $72.75 Million |
0.270x | +414.08% |
| 2017-12-31 | CN¥585.03 Million ≈ $85.61 Million |
CN¥-50.30 Million ≈ $-7.36 Million |
-0.086x | -361.81% |
| 2016-12-31 | CN¥509.40 Million ≈ $74.54 Million |
CN¥16.73 Million ≈ $2.45 Million |
0.033x | +2179.89% |
| 2015-12-31 | CN¥508.35 Million ≈ $74.39 Million |
CN¥-802.68K ≈ $-117.46K |
-0.002x | +98.51% |
| 2014-12-31 | CN¥333.61 Million ≈ $48.82 Million |
CN¥-35.30 Million ≈ $-5.17 Million |
-0.106x | -143.79% |
| 2013-12-31 | CN¥307.51 Million ≈ $45.00 Million |
CN¥-13.35 Million ≈ $-1.95 Million |
-0.043x | -110.74% |
| 2012-12-31 | CN¥263.39 Million ≈ $38.54 Million |
CN¥106.47 Million ≈ $15.58 Million |
0.404x | +160.84% |
| 2011-12-31 | CN¥214.83 Million ≈ $31.44 Million |
CN¥33.29 Million ≈ $4.87 Million |
0.155x | -- |
About Beijing New Oriental Star Petrochemical Engineering Co Ltd
Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is bas… Read more